From IgE to clinical trials of allergic rhinitis

被引:63
作者
Ciprandi, Giorgio [1 ]
Marseglia, Gian Luigi [2 ]
Castagnoli, Riccardo [2 ]
Valsecchi, Chiara [2 ]
Tagliacarne, Carlotta [2 ]
Caimmi, Silvia [2 ]
机构
[1] IRCCS AOU San Martino Genova, Dept Med, Genoa, Italy
[2] Univ Pavia, Fdn IRCCS Policlin San Matteo, Dept Pediat, I-27100 Pavia, Italy
关键词
allergen immunotherapy; allergic rhinitis; IgE; omalizumab; sublingual immunotherapy; 5-GRASS POLLEN TABLET; FC-EPSILON-RI; SUBLINGUAL IMMUNOTHERAPY; SUBCUTANEOUS IMMUNOTHERAPY; COMBINATION TREATMENT; RUSH IMMUNOTHERAPY; IMMUNE-RESPONSES; NASAL-MUCOSA; OMALIZUMAB; EFFICACY;
D O I
10.1586/1744666X.2015.1086645
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The current scientific research is continuously aiming at identifying new therapeutic targets with the purpose of modifying the immune response to allergens. The evolution in immunological methods has led to the identification of immunoglobulin E (IgE) as both a diagnostic biomarker and potential therapeutic target in allergic diseases, such as allergic rhinitis. Allergen immunotherapy has been used for more than 100 years to treat allergic diseases and it is today considered the only disease-modifying treatment capable of inducing a long-lasting immunological and clinical tolerance toward the causal allergen. During the past 20 years, major advances have been made in understanding the molecular and cellular mechanisms of allergen tolerance in humans. Moreover, there has been considerable progress in allergen extract modifications and additions to standard extracts. The recognition that IgE plays a pivotal role in basic regulatory mechanisms of allergic inflammation has recently stimulated research into the therapeutic potential of directly targeting this antibody. Omalizumab, the most advanced humanized anti-IgE monoclonal antibody, is currently approved for the treatment of uncontrolled allergic asthma and chronic spontaneous urticaria. Interesting results also arise from studies in which omalizumab was administered in patients with allergic rhinitis. The aim of this review is to provide an update on current findings on immunological and clinical effects of allergen immunotherapy and anti-IgE therapy, which have been shown to have synergistic modes of action for the treatment of allergic rhinitis.
引用
收藏
页码:1321 / 1333
页数:13
相关论文
共 89 条
[1]   Immunological comparison of allergen immunotherapy tablet treatment and subcutaneous immunotherapy against grass allergy [J].
Aasbjerg, K. ;
Backer, V. ;
Lund, G. ;
Holm, J. ;
Nielsen, N. C. ;
Holse, M. ;
Wagtmann, V. R. ;
Wurtzen, P. A. .
CLINICAL AND EXPERIMENTAL ALLERGY, 2014, 44 (03) :417-428
[2]   CD23/FcεRII: molecular multi-tasking [J].
Acharya, M. ;
Borland, G. ;
Edkins, A. L. ;
MacLellan, L. M. ;
Matheson, J. ;
Ozanne, B. W. ;
Cushley, W. .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2010, 162 (01) :12-23
[3]   Recombinant humanized mAb-E25, an anti-IgE mAb, in birch pollen-induced seasonal allergic rhinitis [J].
Ädelroth, E ;
Rak, S ;
Haahtela, T ;
Aasand, G ;
Rosenhall, L ;
Zetterstrom, O ;
Byrne, A ;
Champain, K ;
Thirlwell, J ;
Della Cioppa, G ;
Sandström, T .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2000, 106 (02) :253-259
[4]   Mechanisms of allergen-specific immunotherapy and immune tolerance to allergens [J].
Akdis, Cezmi A. ;
Akdis, Muebeccel .
WORLD ALLERGY ORGANIZATION JOURNAL, 2015, 8
[5]   Mechanisms of allergen-specific immunotherapy: Multiple suppressor factors at work in immune tolerance to allergens [J].
Akdis, Muebeccel ;
Akdis, Cezmi A. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 133 (03) :621-631
[6]   Efficacy and safety of timothy grass allergy immunotherapy tablets in North American children and adolescents [J].
Blaiss, Michael ;
Maloney, Jennifer ;
Nolte, Hendrik ;
Gawchik, Sandra ;
Yao, Ruji ;
Skoner, David P. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 127 (01) :64-U127
[7]   Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 Revision [J].
Brozek, Jan L. ;
Bousquet, Jean ;
Baena-Cagnani, Carlos E. ;
Bonini, Sergio ;
Canonica, G. Walter ;
Casale, Thomas B. ;
van Wijk, Roy Gerth ;
Ohta, Ken ;
Zuberbier, Torsten ;
Schuenemann, Holger J. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2010, 126 (03) :466-476
[8]   Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy [J].
Bufe, Albrecht ;
Eberle, Peter ;
Franke-Beckmann, Eivy ;
Funck, Juergen ;
Kimmig, Martin ;
Klimek, Ludger ;
Knecht, Roland ;
Stephan, Volker ;
Tholstrup, Bente ;
Weisshaar, Christian ;
Kaiser, Friedrich .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 123 (01) :167-173
[9]   Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus report [J].
Burks, A. Wesley ;
Calderon, Moises A. ;
Casale, Thomas ;
Cox, Linda ;
Demoly, Pascal ;
Jutel, Marek ;
Nelson, Harold ;
Akdis, Cezmi A. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2013, 131 (05) :1288-U65
[10]   Allergen injection immunotherapy for seasonal allergic rhinitis [J].
Calderon, M. A. ;
Alves, B. ;
Jacobson, M. ;
Hurwitz, B. ;
Sheikh, A. ;
Durham, S. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2007, (01)